Gitanjali Jain is the Senior Vice President of Investor Relations and External Affairs at Kezar. With over 15 years in the life science industry, Ms. Jain’s experience spans various roles within investor relations and capital markets. Prior to joining us, she served as Managing Director at Solebury Trout, an investor relations and communications agency, where she strategically advised numerous small and mid-cap biopharmaceutical companies. Ms. Jain was also a research associate at Medarex and StemCells, Inc. where she worked on the development of neural markers as they related to monoclonal antibodies and protein fragments. She also co-authored a publication in the Journal of Neuroscience Research while in that role.

Ms. Jain holds a B.A. in Economics from Brown University and a M.A. in Biology from New York University. She also holds Series 7, 79 and 63 securities licenses.